Could immune cells from your own body help you carry a baby?

NCT ID NCT07230574

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a woman's own immune cells, turned into decidual-like NK cells in a lab and then placed back into her uterus, can improve pregnancy chances. It includes 159 women with abnormal uterine NK cells and a history of reproductive failure. The main goal is to see if more women achieve an ongoing pregnancy (at least 12 weeks) after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

autologous decidual-like NK cells

What this could lead to

If it works, this could offer a new treatment for women with recurrent miscarriage or unexplained infertility linked to abnormal uterine NK cells.

What could go wrong

This is an early phase 2 trial with only 159 participants, so results may not apply to everyone. The therapy is experimental and may not improve pregnancy rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REPRODUCTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Abortion, Missed infertility disorder reproductive system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••